On December 24, 2021, Abpro Bio Co., Ltd. closed the transaction. The company amended the terms of the transaction and issued 7,159,904 shares at a price of KRW 838 for gross proceeds of KRW 5,999,999,552. The transaction involved participation from returning investor Veritas Fund.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
503 KRW | -1.37% |
|
+2.24% | -7.71% |
1st Jan change | Capi. | |
---|---|---|
-7.71% | 103M | |
+62.16% | 3.75B | |
-2.17% | 1.98B | |
-20.17% | 1.57B | |
+34.65% | 1.55B | |
-18.36% | 1.51B | |
+77.08% | 1.49B | |
-12.20% | 1.44B | |
-10.43% | 1.3B | |
+2.77% | 1.15B |
- Stock Market
- Equities
- A195990 Stock
- News Abpro Bio Co., Ltd.
- Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding